Toggle Main Menu Toggle Search

Open Access padlockePrints

Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents in combined treatment with cisplatin in ovarian cancer

Lookup NU author(s): Maryam Zanjirband Zanjirband, Professor Richard Edmondson, Professor John LunecORCiD



This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Zanjirband M, Edmondson RJ, Lunec J

Publication type: Article

Publication status: Published

Journal: Oncotarget

Year: 2016

Volume: 7

Issue: 26

Pages: 40115-40134

Online publication date: 20/05/2016

Acceptance date: 26/04/2016

Date deposited: 06/07/2016

ISSN (electronic): 1949-2553

Publisher: Impact Journals


DOI: 10.18632/oncotarget.9499

PubMed id: 27223080


Altmetrics provided by Altmetric


Funder referenceFunder name
Northern Cancer Care & Research Society
C27826/A11524Cancer Research UK
C0190R4011Newcastle University & Northern Institute for Cancer Research
C240/A1571Cancer Research UK